257
Views
73
CrossRef citations to date
0
Altmetric
Research Article

Acute Hepatitis Induced by Kava Kava

ARTICLE

, &
Pages 109-113 | Published online: 04 Sep 2003

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Michael Murray. (2012) Toxicological Actions of Plant-Derived and Anthropogenic Methylenedioxyphenyl-Substituted Chemicals in Mammals and Insects. Journal of Toxicology and Environmental Health, Part B 15:6, pages 365-395.
Read now
Lei Guo, Nan Mei, Qingsu Xia, Tao Chen, Po-Chuen Chan & PeterP. Fu. (2010) Gene Expression Profiling as an Initial Approach for Mechanistic Studies of Toxicity and Tumorigenicity of Herbal Plants and Herbal Dietary Supplements. Journal of Environmental Science and Health, Part C 28:1, pages 60-87.
Read now
PETERP. FU, HSIU-MEI CHIANG, QINGSU XIA, TAO CHEN, BAI HSIUN CHEN, JUE-JIE YIN, KUO-CHING WEN, GE LIN & HONGTAO YU. (2009) Quality Assurance and Safety of Herbal Dietary Supplements. Journal of Environmental Science and Health, Part C 27:2, pages 91-119.
Read now
PeterP. Fu, Qingsu Xia, Lei Guo, Hongtao Yu & Po-Chuen Chan. (2008) Toxicity of Kava Kava. Journal of Environmental Science and Health, Part C 26:1, pages 89-112.
Read now
Catherine Ulbricht, Ethan Basch, Heather Boon, Edzard Ernst, Paul Hammerness, David Sollars, Candy Tsourounis, Jen Woods & Stephen Bent. (2005) Safety review of kava (Piper methysticum) by the Natural Standard Research Collaboration. Expert Opinion on Drug Safety 4:4, pages 779-794.
Read now
Christine A. Haller, Kathryn H. Meier & Kent R. Olson. (2005) Seizures Reported in Association with Use of Dietary Supplements. Clinical Toxicology 43:1, pages 23-30.
Read now
Ethan M. Basch, Julie C. Servoss & Usha B. Tedrow. (2005) Safety Assurances for Dietary Supplements. Journal Of Herbal Pharmacotherapy 5:1, pages 3-15.
Read now

Articles from other publishers (66)

José M. Pinazo-Bandera, Miren García-Cortés, Antonio Segovia-Zafra, María Isabel Lucena & Raúl J. Andrade. (2022) Recreational Drugs and the Risk of Hepatocellular Carcinoma. Cancers 14:21, pages 5395.
Crossref
Rita B. Soares, Ricardo Jorge Dinis-Oliveira & Nuno G. Oliveira. (2022) An Updated Review on the Psychoactive, Toxic and Anticancer Properties of Kava. Journal of Clinical Medicine 11:14, pages 4039.
Crossref
Vinícius Remus Ballotin, Lucas Goldmann Bigarella, Ajacio Bandeira de Mello Brandão, Raul Angelo Balbinot, Silvana Sartori Balbinot & Jonathan Soldera. (2021) Herb-induced liver injury: Systematic review and meta-analysis. World Journal of Clinical Cases 9:20, pages 5490-5513.
Crossref
Nan Mei, Tao Chen, Baitang Ning & Lei Guo. 2021. Nutraceuticals. Nutraceuticals 299 313 .
Ajay Srivastava & Prafulla Kumar. 2021. Nutraceuticals. Nutraceuticals 63 72 .
Palaniappan Saravanapriya & Kasi Pandima Devi. 2021. Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases. Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases 259 287 .
Amy Christine Brown. (2017) Liver toxicity related to herbs and dietary supplements: Online table of case reports. Part 2 of 5 series. Food and Chemical Toxicology 107, pages 472-501.
Crossref
Christian Frenzel & Rolf Teschke. (2016) Herbal Hepatotoxicity: Clinical Characteristics and Listing Compilation. International Journal of Molecular Sciences 17:5, pages 588.
Crossref
Flaminia Pantano, Roberta Tittarelli, Giulio Mannocchi, Simona Zaami, Serafino Ricci, Raffaele Giorgetti, Daniela Terranova, Francesco Busardò & Enrico Marinelli. (2016) Hepatotoxicity Induced by “the 3Ks”: Kava, Kratom and Khat. International Journal of Molecular Sciences 17:4, pages 580.
Crossref
Nan Mei, Jiekun Xuan, Tao Chen, Baitang Ning & Lei Guo. 2016. Nutraceuticals. Nutraceuticals 249 262 .
Dong Fu & Iqbal Ramzan. 2015. Phytotherapies. Phytotherapies 312 329 .
Xiaoyan Chen. 2014. Handbook of Metabolic Pathways of Xenobiotics. Handbook of Metabolic Pathways of Xenobiotics 1 64 .
Kenneth J. Sufka, Melissa J. Loria, Kevin Lewellyn, Jordan K. Zjawiony, Zulfiqar Ali, Naohito Abe & Ikhlas A. Khan. (2014) The effect of Salvia divinorum and Mitragyna speciosa extracts, fraction and major constituents on place aversion and place preference in rats. Journal of Ethnopharmacology 151:1, pages 361-364.
Crossref
Adejuwon Adewale Adeneye. 2014. Toxicological Survey of African Medicinal Plants. Toxicological Survey of African Medicinal Plants 99 133 .
Paula Gardiner, Denise Adams, Amanda C. Filippelli, Hafsa Nasser, Robert Saper, Laura White & Sunita Vohra. (2013) A Systematic Review of the Reporting of Adverse Events Associated with Medical Herb use among Children. Global Advances in Health and Medicine 2:2, pages 46-55.
Crossref
Anselm Wong, Zeff Koutsogiannis, Shaun Greene & Shona McIntyre. (2013) A case of hemolysis and methemoglobinemia following amyl nitrite use in?an individual with G6PD deficiency. Journal of Acute Medicine 3:1, pages 23-25.
Crossref
Dominique Larrey & Marie-Pierre Ripault. 2013. Drug-Induced Liver Disease. Drug-Induced Liver Disease 443 462 .
Rolf Teschke, Albrecht Wolff, Christian Frenzel, Johannes Schulze & Axel Eickhoff. (2012) Herbal hepatotoxicity: a tabular compilation of reported cases. Liver International 32:10, pages 1543-1556.
Crossref
V Garg. (2012) Facts about standardization of herbal medicine: a review. Journal of Chinese Integrative Medicine, pages 1077-1083.
Crossref
Amitava Dasgupta. 2012. Resolving Erroneous Reports in Toxicology and Therapeutic Drug Monitoring. Resolving Erroneous Reports in Toxicology and Therapeutic Drug Monitoring 185 211 .
Ryan Bodkin, Sandra Schneider, Donna Rekkerth, Linda Spillane & Michael Kamali. (2012) Rhabdomyolysis associated with kava ingestion. The American Journal of Emergency Medicine 30:4, pages 635.e1-635.e3.
Crossref
Robert Clark Schutt, Claudio Ronco & Mitchell H. Rosner. (2012) The Role of Therapeutic Plasma Exchange in Poisonings and Intoxications. Seminars in Dialysis 25:2, pages 201-206.
Crossref
Rolf Teschke, Jerome Sarris & Isaac Schweitzer. (2012) Kava hepatotoxicity in traditional and modern use: the presumed Pacific kava paradox hypothesis revisited. British Journal of Clinical Pharmacology 73:2, pages 170-174.
Crossref
Karim Sedky, Racha Nazir, Aditya Joshi, Gagandeep Kaur & Steven Lippmann. (2012) Which psychotropic medications induce hepatotoxicity?. General Hospital Psychiatry 34:1, pages 53-61.
Crossref
Doris B. Strader, Victor J. Navarro & Leonard B. Seeff. 2012. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology 462 475 .
James H. Lewis & David E. Kleiner. 2012. MacSween's Pathology of the Liver. MacSween's Pathology of the Liver 645 760 .
Chit Shing Jackson Woo, Jonathan See Han Lau & Hani El-Nezami. 2012. Recent Trends in Medicinal Plants Research. Recent Trends in Medicinal Plants Research 365 384 .
Sylvie Stacy. (2011) Relaxation Drinks and Their Use in Adolescents. Journal of Child and Adolescent Psychopharmacology 21:6, pages 605-610.
Crossref
Mamta Behl, Abraham Nyska, Rajendra S. Chhabra, Gregory S. Travlos, Laurene M. Fomby, Barney R. Sparrow, Milton R. Hejtmancik & Po C. Chan. (2011) Liver toxicity and carcinogenicity in F344/N rats and B6C3F1 mice exposed to Kava Kava. Food and Chemical Toxicology 49:11, pages 2820-2829.
Crossref
Rolf Teschke & Vincent Lebot. (2011) Proposal for a Kava Quality Standardization Code. Food and Chemical Toxicology 49:10, pages 2503-2516.
Crossref
Ping Zhou, Shimon Gross, Ji-Hua Liu, Bo-Yang Yu, Ling-Ling Feng, Jan Nolta, Vijay Sharma, David Piwnica-Worms & Samuel X. Qiu. (2010) Flavokawain B, the hepatotoxic constituent from kava root, induces GSH‐sensitive oxidative stress through modulation of IKK/NF‐κB and MAPK signaling pathways. The FASEB Journal 24:12, pages 4722-4732.
Crossref
Rolf Teschke. (2010) Kava hepatotoxicity: pathogenetic aspects and prospective considerations. Liver International 30:9, pages 1270-1279.
Crossref
Jiwon W. Kim, Akiko Hattori & Paula V. Phongsamran. (2010) Drug-Induced Liver Disease. Critical Care Nursing Clinics of North America 22:3, pages 323-334.
Crossref
R. Teschke & A. Wolff. (2009) Kava hepatotoxicity: Regulatory data selection and causality assessment. Digestive and Liver Disease 41:12, pages 891-901.
Crossref
Valerie Robinson, Wilma F. Bergfeld, Donald V. Belsito, Curtis D. Klaassen, James G. Marks, Ronald C. Shank, Thomas J. Slaga, Paul W. Snyder & F. Alan Andersen. (2009) Final Report on the Safety Assessment of Piper Methysticum Leaf/Root/Stem Extract and Piper Methysticum Root Extract. International Journal of Toxicology 28:6_suppl, pages 175S-188S.
Crossref
Stacy S. ShordKanan Shah & Alvina Lukose. (2009) Drug—Botanical Interactions: A Review of the Laboratory, Animal, and Human Data for 8 Common Botanicals. Integrative Cancer Therapies 8:3, pages 208-227.
Crossref
Rolf Teschke, Alexander Genthner & Albrecht Wolff. (2009) Kava hepatotoxicity: Comparison of aqueous, ethanolic, acetonic kava extracts and kava–herbs mixtures. Journal of Ethnopharmacology 123:3, pages 378-384.
Crossref
Valerie Robinson, Wilma F. Bergfeld, Donald V. Belsito, Curtis D. Klaassen, James G. MarksJr.Jr., Ronald C. Shank, Thomas J. Slaga, Paul W. Snyder & F. Alan Andersen. (2019) Final Report on the Safety Assessment of Piper Methysticum Leaf/Root/Stem Extract and Piper Methysticum Root Extract . International Journal of Toxicology 28:2_suppl, pages 175S-188S.
Crossref
Lei Guo, Quanzhen Li, Qingsu Xia, Stacey Dial, Po-Chuen Chan & Peter Fu. (2009) Analysis of gene expression changes of drug metabolizing enzymes in the livers of F344 rats following oral treatment with kava extract. Food and Chemical Toxicology 47:2, pages 433-442.
Crossref
May Loo. 2009. Integrative Medicine for Children. Integrative Medicine for Children 106 130 .
Christine A. Haller. 2009. Pharmacology and Therapeutics. Pharmacology and Therapeutics 1237 1245 .
Lingtak-Neander Chan. 2010. Handbook of Drug-Nutrient Interactions. Handbook of Drug-Nutrient Interactions 341 366 .
Donald G. Barceloux. 2008. Medical Toxicology of Natural Substances. Medical Toxicology of Natural Substances 525 531 .
D Jesse Wagstaff. 2008. International Poisonous Plants Checklist. International Poisonous Plants Checklist 287 326 .
S. Herrera & M. Bruguera. (2008) Hepatotoxicidad inducida por el uso de hierbas y medicamentos para perder peso. Gastroenterología y Hepatología 31:7, pages 447-453.
Crossref
Priyadarshini Raman, David L. DeWitt & Muraleedharan G. Nair. (2007) Lipid peroxidation and cyclooxygenase enzyme inhibitory activities of acidic aqueous extracts of some dietary supplements. Phytotherapy Research 22:2, pages 204-212.
Crossref
Saskia Lüde, Michael Török, Sandy Dieterle, René Jäggi, Karin Berger Büter & Stephan Krähenbühl. (2008) Hepatocellular toxicity of kava leaf and root extracts. Phytomedicine 15:1-2, pages 120-131.
Crossref
Amitava Dasgupta. 2008. Handbook of Drug Monitoring Methods. Handbook of Drug Monitoring Methods 235 261 .
Leonard B. Seeff. (2007) Herbal Hepatotoxicity. Clinics in Liver Disease 11:3, pages 577-596.
Crossref
Dominique Larrey. 2007. Drug-Induced Liver Disease, Second Edition. Drug-Induced Liver Disease, Second Edition 507 526 .
Natasha P. Clayton, Katsuhiko Yoshizawa, Grace E. Kissling, Leo T. Burka, Po-Chuen Chan & Abraham Nyska. (2007) Immunohistochemical analysis of expressions of hepatic cytochrome P450 in F344 rats following oral treatment with kava extract. Experimental and Toxicologic Pathology 58:4, pages 223-236.
Crossref
ADRIANE FUGH-BERMAN. 2007. Treatment of the Postmenopausal Woman. Treatment of the Postmenopausal Woman 683 690 .
L.A. Mitscher. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II 405 430 .
Amitava DasguptaDavid W. Bernard. (2006) Herbal Remedies: Effects on Clinical Laboratory Tests. Archives of Pathology & Laboratory Medicine 130:4, pages 521-528.
Crossref
R. Brent Furbee, Kevin S. Barlotta, Melrose Kanku Allen & Christopher P. Holstege. (2006) Hepatotoxicity Associated with Herbal Products. Clinics in Laboratory Medicine 26:1, pages 227-241.
Crossref
Felix Stickel, Eleonora Patsenker & Detlef Schuppan. (2005) Herbal hepatotoxicity. Journal of Hepatology 43:5, pages 901-910.
Crossref
K N Woodward. (2016) The potential impact of the use of homeopathic and herbal remedies on monitoring the safety of prescription products. Human & Experimental Toxicology 24:5, pages 219-233.
Crossref
Willis C Maddrey. (2005) Drug-Induced Hepatotoxicity. Journal of Clinical Gastroenterology 39:4, pages S83-S89.
Crossref
Ivonne M. C. M. Rietjens, Martijn J. Martena, Marelle G. Boersma, Wim Spiegelenberg & Gerrit M. Alink. (2005) Molecular mechanisms of toxicity of important food-borne phytotoxins. Molecular Nutrition & Food Research 49:2, pages 131-158.
Crossref
Yuzhong Ma, Karuna Sachdeva, Jirong Liu, Michael Ford, Dongfang Yang, Ikhlas A. Khan, Clinton O. Chichester & Bingfang Yan. (2004) DESMETHOXYYANGONIN AND DIHYDROMETHYSTICIN ARE TWO MAJOR PHARMACOLOGICAL KAVALACTONES WITH MARKED ACTIVITY ON THE INDUCTION OF CYP3A23. Drug Metabolism and Disposition 32:11, pages 1317-1324.
Crossref
Alex Sparreboom, Michael C. Cox, Milin R. Acharya & William D. Figg. (2004) Herbal Remedies in the United States: Potential Adverse Interactions With Anticancer Agents. Journal of Clinical Oncology 22:12, pages 2489-2503.
Crossref
Keith I. Block, Charlotte GyllenhaalMark N. Mead. (2016) Safety and Efficacy of Herbal Sedatives in Cancer Care. Integrative Cancer Therapies 3:2, pages 128-148.
Crossref
Eddy Pak, Karl T. Esrason & Victor H. Wu. (2016) Hepatotoxicity of Herbal Remedies: An Emerging Dilemma. Progress in Transplantation 14:2, pages 91-96.
Crossref
Laurent Peyrin-Biroulet, Hélène Barraud, Fabien Petit-Laurent, David Ancel, Jérôme Watelet, Laurence Chone, Hervé Hudziak, Marc-André Bigard & Jean-Pierre Bronowicki. (2004) Hépatotoxicité de la phytothérapie : données cliniques, biologiques, histologiques et mécanismes en cause pour quelques exemples caractéristiques. Gastroentérologie Clinique et Biologique 28:6-7, pages 540-550.
Crossref
Aline Charabaty Pishvaian, Bradley W. Trope & James H. Lewis. (2004) Drug-induced liver disease in 2003. Current Opinion in Gastroenterology 20:3, pages 208-219.
Crossref
U Werneke, J Earl, C Seydel, O Horn, P Crichton & D Fannon. (2004) Potential health risks of complementary alternative medicines in cancer patients. British Journal of Cancer 90:2, pages 408-413.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.